Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  mesna
Find trials that include:  Any drugs shown
Results 1-21 of 21 for your search:
Start Over
Panobinostat and Combination Chemotherapy in Treating Patients with Relapsed or Refractory Hodgkin Lymphoma
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2010-0065, NCI-2012-01779, NCI-2010-01770, NCT01169636
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Older Patients with Previously Untreated Acute Lymphoblastic Leukemia
Phase: Phase II, Phase I
Type: Treatment
Age: 60 and over
Trial IDs: 2010-0991, NCI-2011-01123, NCT01371630
Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients with Stage III or Metastatic Melanoma
Phase: Phase II, Phase I
Type: Treatment
Age: 14 and over
Trial IDs: 2009-0471, NCI-2014-02655, NCT01740557
Natural Killer Cells before and after Donor Stem Cell Transplant in Treating Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Phase: Phase II, Phase I
Type: Treatment
Age: 2 to 65
Trial IDs: 2012-0708, NCI-2013-02183, 05-07-04832, P01 - 5P01, RP110553 05-07-04832, NCT01904136
Palifermin in Preventing Graft-versus-Host Disease in Patients with Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Phase: Phase II, Phase I
Type: Prevention
Age: 18 to 70
Trial IDs: 15-C-0067, NCI-2015-00084, 150067, NCT02356159
Donor Umbilical Cord Blood Transplant After Combination Chemotherapy and Total-Body Irradiation in Treating Younger Patients With High-Risk Hematologic Malignancies
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and under
Trial IDs: UCBT01, NCI-2011-03700, NCT01328496
Ofatumumab, Combination Chemotherapy, and Filgrastim Before Stem Cell Collection in Treating Patients with Non-Hodgkin Lymphoma
Phase: Phase II
Type: Treatment
Age: 18 to 70
Trial IDs: 2009-0796, NCI-2011-01068, NCT01329900
Combination Chemotherapy and Ofatumumab in Treating Patients with Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Phase: Phase II
Type: Treatment
Age: Not specified
Trial IDs: 2010-0708, NCI-2011-01061, NCT01363128
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients with Acute Lymphoblastic Leukemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2011-0030, NCI-2011-02941, NCT01424982
Donor Progenitor Cell and Natural Kill Cell Transplant in Treating Younger Patients with High-Risk Hematologic Malignancies
Phase: Phase II
Type: Treatment
Age: 21 and under
Trial IDs: HAPNK1, NCI-2013-00609, NCT01807611
Combination Chemotherapy and Radiation Therapy in Treating Patients with Newly Diagnosed Stage I-II Nasal NK Cell Lymphoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0367, NCI-2014-01356, NCT02106988
Chemotherapy before and after Donor Bone Marrow Transplant in Treating Younger Patients with Hematologic Cancer
Phase: Phase II
Type: Treatment
Age: 6 months to 25 years
Trial IDs: J13161, NCI-2014-01899, CIR00009809, NA_00091665, NA_00091665 / CIR00003493, NA_00091665 / CIR00009809, NCT02120157
Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients with Newly Diagnosed Mantle Cell Lymphoma
Phase: Phase II
Type: Treatment
Age: 18 to less than 65
Trial IDs: 2014-0559, NCI-2015-00960, NCT02427620
Lenalidomide and Dexamethasone With or Without Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage II-III Multiple Myeloma
Phase: Phase II
Type: Treatment
Age: 18 to 75
Trial IDs: AAAJ2355, NCI-2013-00547, NCT01731866
Phase I Study of Romidepsin Plus ICE for Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2012-0183, NCI-2012-00847, NCT01590732
Nonmyeloablative Peripheral Blood Stem Cell Transplant in Treating Patients with Hematologic Malignancies
Phase: No phase specified
Type: Treatment
Age: 18 to 70
Trial IDs: UPCI 13-131, NCI-2014-02371, NCT02167958
Surgery and Combination Chemotherapy in Treating Younger Patients with Non-metastatic Standard-Risk Medulloblastoma
Phase: No phase specified
Type: Treatment
Age: 3 to 18
Trial IDs: J1403, NCI-2014-01870, CIR00004694, NA_00091840, NA_00091840 / CIR00004694, NCT02212574
Combination Chemotherapy in Treating Patients with Newly Diagnosed, Previously Untreated Intraocular Retinoblastoma
Phase: No phase specified
Type: Treatment
Age: Not specified
Trial IDs: SJRET6, NCI-2013-00409, NCT01783535
Start Over